Literature DB >> 26881190

Cytopathologic diagnosis of fine needle aspiration biopsies of thyroid nodules.

Evangelos P Misiakos1, Niki Margari1, Christos Meristoudis1, Nickolas Machairas1, Dimitrios Schizas1, Konstantinos Petropoulos1, Aris Spathis1, Petros Karakitsos1, Anastasios Machairas1.   

Abstract

Fine-needle aspiration (FNA) cytology is an important diagnostic tool in patients with thyroid lesions. Several systems have been proposed for the cyropathologic diagnosis of the thyroid nodules. However cases with indeterminate cytological findings still remain a matter of debate. In this review we analyze all literature regarding Thyroid Cytopathology Reporting systems trying to identify the most suitable methodology to use in clinical practice for the preoperative diagnosis of thyroid nodules. A review of the English literature was conducted, and data were analyzed and summarized and integrated from the authors' perspective. The main purpose of thyroid FNA is to identify patients with higher risk for malignancy, and to prevent unnecessary surgeries for benign conditions. The Bethesda System for Reporting Thyroid Cytopathology is the most widely used system for the diagnosis of thyroid FNA specimens. This system also contains guidelines for the diagnosis and treatment of indeterminate or suspicious for malignancy cases. In conclusion, patients who require repeated FNAs for indeterminate diagnoses will be resolved by repeat FNA in a percentage of 72%-80%.

Entities:  

Keywords:  Biopsy; Cytopathology; Fine needle; Nodule; Papillary cancer; Thyroid

Year:  2016        PMID: 26881190      PMCID: PMC4733475          DOI: 10.12998/wjcc.v4.i2.38

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  56 in total

1.  Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007.

Authors:  S Piana; A Frasoldati; M Ferrari; R Valcavi; E Froio; V Barbieri; C Pedroni; G Gardini
Journal:  Cytopathology       Date:  2010-07-06       Impact factor: 2.073

Review 2.  Thyroid aspiration cytology: current status.

Authors:  Lester J Layfield; Edmund S Cibas; Hossein Gharib; Susan J Mandel
Journal:  CA Cancer J Clin       Date:  2009 Mar-Apr       Impact factor: 508.702

3.  The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.

Authors:  Constantine G A Theoharis; Kevin M Schofield; Lynwood Hammers; Robert Udelsman; David C Chhieng
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions.

Authors:  Jennifer L Rabaglia; Wareef Kabbani; Lucy Wallace; Shelby Holt; Lori Watumull; Jeffrey Pruitt; William H Snyder; Fiemu E Nwariaku
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

5.  Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases.

Authors:  Y S Venkatesh; N G Ordonez; P N Schultz; R C Hickey; H Goepfert; N A Samaan
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

6.  Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.

Authors:  Silvia Cantara; Marco Capezzone; Stefania Marchisotta; Serena Capuano; Giulia Busonero; Paolo Toti; Andrea Di Santo; Giuseppe Caruso; Anton Ferdinando Carli; Lucia Brilli; Annalisa Montanaro; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

Review 7.  Fine-needle aspiration of thyroid nodules: past, present, and future.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pract       Date:  2004 May-Jun       Impact factor: 3.443

8.  Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules.

Authors:  Zubair Baloch; Virginia A LiVolsi; Pooja Jain; Rishi Jain; Ibrahim Aljada; Susan Mandel; Jill E Langer; Prabodh K Gupta
Journal:  Diagn Cytopathol       Date:  2003-10       Impact factor: 1.582

9.  Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".

Authors:  N Paul Ohori; Marina N Nikiforova; Karen E Schoedel; Shane O LeBeau; Steven P Hodak; Raja R Seethala; Sally E Carty; Jennifer B Ogilvie; Linwah Yip; Yuri E Nikiforov
Journal:  Cancer Cytopathol       Date:  2010-02-25       Impact factor: 5.284

10.  Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.

Authors:  Armando C Filie; Sylvia L Asa; Kim R Geisinger; Sanjay Logani; Maria Merino; Yuri E Nikiforov; Douglas P Clark
Journal:  Diagn Cytopathol       Date:  2008-06       Impact factor: 1.582

View more
  11 in total

1.  The Use of Dynamic Contrast-Enhanced Perfusion MRI in Differentiating Benign and Malignant Thyroid Nodules.

Authors:  Muhammed Sedat Sakat; Recep Sade; Korhan Kilic; Mustafa Sıtkı Gözeler; Osman Pala; Gökhan Polat; Mecit Kantarcı
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-10-15

Review 2.  Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.

Authors:  Carles Zafon; Juan J Díez; Juan C Galofré; David S Cooper
Journal:  Eur Thyroid J       Date:  2017-03-03

3.  Metas-Chip precisely identifies presence of micrometastasis in live biopsy samples by label free approach.

Authors:  Mohammad Saeid Nikshoar; Mohammad Ali Khayamian; Saeid Ansaryan; Hassan Sanati; Milad Gharooni; Leila Farahmand; Farshad Rezakhanloo; Keivan Majidzadeh-A; Parisa Hoseinpour; Shahrzad Dadgari; Leila Kiani-M; Mohammad Saqafi; Masoumeh Gity; Mohammad Abdolahad
Journal:  Nat Commun       Date:  2017-12-19       Impact factor: 14.919

4.  The Usefulness of Immunocytochemistry of CD56 in Determining Malignancy from Indeterminate Thyroid Fine-Needle Aspiration Cytology.

Authors:  Hyunseo Cha; Ju Yeon Pyo; Soon Won Hong
Journal:  J Pathol Transl Med       Date:  2018-10-15

Review 5.  Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives.

Authors:  Ling-Rui Li; Bo Du; Han-Qing Liu; Chuang Chen
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

6.  Ultrasound Parameters of Thyroid Nodules and the Risk of Malignancy: A Retrospective Analysis.

Authors:  Minxin Wang; Ping Sun; Xiaodong Zhao; Yongmei Sun
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

7.  BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.

Authors:  Huang Chen; Aiping Song; Ye Wang; Yifan He; Jie Tong; Jinxi Di; Chun Li; Zhongren Zhou; Xiaopin Cai; Dingrong Zhong; Jiping Da
Journal:  Cancer Med       Date:  2021-12-01       Impact factor: 4.452

8.  Identification of a 3-Gene Prognostic Index for Papillary Thyroid Carcinoma.

Authors:  Lin-Kun Zhong; Xing-Yan Deng; Fei Shen; Wen-Song Cai; Jian-Hua Feng; Xiao-Xiong Gan; Shan Jiang; Chi-Zhuai Liu; Ming-Guang Zhang; Jiang-Wei Deng; Bing-Xing Zheng; Xiao-Zhang Xie; Li-Qing Ning; Hui Huang; Shan-Shan Chen; Jian-Hang Miao; Bo Xu
Journal:  Front Mol Biosci       Date:  2022-03-16

9.  Identification of benign and malignant thyroid nodules by in vivo iodine concentration measurement using single-source dual energy CT: A retrospective diagnostic accuracy study.

Authors:  Shun-Yu Gao; Xiao-Yan Zhang; Wei Wei; Xiao-Ting Li; Yan-Ling Li; Min Xu; Ying-Shi Sun; Xiao-Peng Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

10.  Targeted Mutational Profiling and a Powerful Risk Score as Additional Tools for the Diagnosis of Papillary Thyroid Cancer.

Authors:  Barbara Kocsis-Deák; Kristóf Árvai; Bernadett Balla; Bálint Tóbiás; Andrea Kohánka; Balázs Járay; János Horányi; János Podani; István Takács; Zsuzsanna Putz; János Kósa; Péter Lakatos
Journal:  Pathol Oncol Res       Date:  2019-11-22       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.